The objective of this project is to develop the leads which result from the contract effort (N01CM67868) concerned with the screening of compounds for radiosensitizing activity. Analogs of the lead compounds will be synthesized and tested in vitro. The analogs will be developed using the knowledge of the relationship between molecular structure and radiosensitizing effectiveness which has accumulated from past and current studies. New and/or novel radiosensitizers for introduction into the clinic are expected from the proposed project.

Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM007321-000
Application #
3607992
Study Section
Project Start
1990-09-30
Project End
1993-09-29
Budget Start
1990-09-30
Budget End
1991-09-29
Support Year
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Auckland
Department
Type
DUNS #
City
Auckland
State
Country
New Zealand
Zip Code
1010